Repare Therapeutics Inc. — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Repare Therapeutics Inc. (RPTX)
CIK: 0001808158
Period of Report: 2021-12-10

Reporting Person: Koehler Maria (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-10	Common Shares	M	48460	$2.062	Acquired	100955	Direct
2021-12-10	Common Shares	M	51	$2.425	Acquired	101006	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-10	Employee Stock Option (right to buy)	$2.062	M	48460	Disposed	2029-05-01	Common Shares (48460)	Direct
2021-12-10	Employee Stock Option (right to buy)	$2.425	M	51	Disposed	2029-12-16	Common Shares (51)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vested on May 1, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F2: Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.